- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Reduced habit-driven errors in Parkinson’s Disease ; volume:9 ; number:1 ; day:4 ; month:3 ; year:2019 ; pages:1-8 ; date:12.2019
Scientific reports ; 9, Heft 1 (4.3.2019), 1-8, 12.2019
- Creator
-
Bannard, Colin
Leriche, Mariana
Bandmann, Oliver
Brown, Christopher H.
Ferracane, Elisa
Sánchez-Ferro, Álvaro
Obeso, José
Redgrave, Peter
Stafford, Tom
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-39294-z
- URN
-
urn:nbn:de:101:1-2019032501100096385046
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bannard, Colin
- Leriche, Mariana
- Bandmann, Oliver
- Brown, Christopher H.
- Ferracane, Elisa
- Sánchez-Ferro, Álvaro
- Obeso, José
- Redgrave, Peter
- Stafford, Tom
- SpringerLink (Online service)
Other Objects (12)
Reduced penetrance of Parkinson’s disease models
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
Data-Driven Subtyping of Parkinson’s Using Acoustic Analysis of Sustained Vowels and Cluster Analysis: Findings in the Parkinson’s Voice Initiative Study
Reduced penetrance of Parkinson’s disease models
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
Data-Driven Subtyping of Parkinson’s Using Acoustic Analysis of Sustained Vowels and Cluster Analysis: Findings in the Parkinson’s Voice Initiative Study
Reduced penetrance of Parkinson’s disease models
Genotype-driven therapeutic developments in Parkinson’s disease
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
Data Driven Methods for Mobile Gait Analysis in Parkinson’s Disease
Data-Driven Models for Objective Grading Improvement of Parkinson’s Disease
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease